Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „seen“
Suchtreffer
Begriffe & Kennungen
Azarga · 4.8 · Timolol is absorbed into the systemic circulation. This may cause similar adverse reactions as seen with syste
Eintrag öffnenAzomyr · 4.8 · System Organ Class Frequency Adverse reactions seen with Azomyr Metabolism and nutrition Not known Increased a
Eintrag öffnenBexsero · 4.8 · No increase in the incidence or severity of the adverse reactions was seen with subsequent doses of the vaccin
Eintrag öffnenBimervax · 4.8 · The overall safety profile for the BIMERVAX XBB.1.16 booster dose was similar to that seen after the BIMERVAX
Eintrag öffnenBimervax · 4.8 · The overall safety profile for the BIMERVAX XBB.1.16 booster dose was similar to that seen after the BIMERVAX
Eintrag öffnenBimervax · 4.8 · The overall safety profile for the BIMERVAX XBB.1.16 booster dose was similar to that seen after the BIMERVAX
Eintrag öffnenBlincyto · 4.8 · The adverse reactions in BLINCYTO-treated paediatric patients were similar in type to those seen in adult pati
Eintrag öffnenBrilique · 4.8 · Increased bleeding patterns similar to TIMI Major were seen for TIMI Major or Minor and PLATO Major and PLATO
Eintrag öffnenBrilique · 4.8 · Increased bleeding patterns similar to TIMI Major were seen for TIMI Major or Minor and PLATO Major and PLATO
Eintrag öffnenBrilique · 4.8 · Increased bleeding patterns similar to TIMI Major were seen for TIMI Major or Minor and PLATO Major and PLATO
Eintrag öffnenBrinavess · 4.8 · The most commonly reported adverse reactions (> 5 %) seen in the first 24 hours after receiving vernakalant we
Eintrag öffnenCapecitabine Accord · 4.8 · 15 Some of the ADRs are reactions commonly seen with the combination medicinal product (e.g. peripheral sensor
Eintrag öffnenCapecitabine Teva · 4.8 · Some of the ADRs are reactions commonly seen with the combination medicinal product (e.g. peripheral sensory n
Eintrag öffnenComirnaty · 4.8 · 113 The overall safety profile of Comirnaty in adolescents 12 to 15 years of age was similar to that seen in p
Eintrag öffnenComirnaty · 4.8 · 150 The overall safety profile of Comirnaty in adolescents 12 to 15 years of age was similar to that seen in p
Eintrag öffnenComirnaty · 4.8 · 7 The overall safety profile of Comirnaty in adolescents 12 to 15 years of age was similar to that seen in par
Eintrag öffnenComirnaty · 4.8 · 76 The overall safety profile of Comirnaty in adolescents 12 to 15 years of age was similar to that seen in pa
Eintrag öffnenComirnaty · 4.8 · The overall safety profile for the booster dose was similar to that seen after 2 doses. The most frequent adve
Eintrag öffnenComirnaty · 4.8 · The overall safety profile for the booster dose was similar to that seen after 2 doses. The most frequent adve
Eintrag öffnenComirnaty · 4.8 · The overall safety profile for the booster dose was similar to that seen after 2 doses. The most frequent adve
Eintrag öffnen